JDB Pharmaceutical Project Private Limited
About JDB Pharmaceutical Project Private Limited
Data last updated:
JDB Pharmaceutical Project Private Limited was a private limited company based in Ahmedabad, Gujarat, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 15 April 2011.
The company was registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2011PTC064962.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Vishal Palabhai Rudach and Devalben Bhaveshkumar Movar.
Its last annual general meeting (AGM) was held on 16 August 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office was at Ahmedabad, Gujarat.
Company details
Contact details
JDB Pharmaceutical Project Private Limited's registered office is in Ahmedabad, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShyamdeep Advisory Services Pvt Ltd Pushpan Complex Opp. Seema Hall Sateli, Te, Ahmedabad, Gujarat, India – 380054
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of JDB Pharmaceutical Project Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of JDB Pharmaceutical Project is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of JDB Pharmaceutical Project Private Limited
FY 2020 filings availableFinancial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of JDB Pharmaceutical Project Private Limited, buy the company report.
Board of directors of JDB Pharmaceutical Project Private Limited
JDB Pharmaceutical Project has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vishal Palabhai Rudach Also directs: Aqualand Infraprojects Private Limited | Director | 12 Mar 2018 | 8 Years 7 Months | As last reported |
| Devalben Bhaveshkumar Movar Also directs: Kuvar Industrial Estate Private Limited | Director | 12 Mar 2018 | 8 Years 7 Months | As last reported |
Auditor
JDB Pharmaceutical Project Private Limited is audited by CHINTAN PARIKH & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| CHINTAN PARIKH & CO. | FY 2017 | 131255W |
Shareholding
The shareholding of JDB Pharmaceutical Project Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of JDB Pharmaceutical Project Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving JDB Pharmaceutical Project Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for JDB Pharmaceutical Project Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for JDB Pharmaceutical Project Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
JDB Pharmaceutical Project Private Limited has 4 board changes on record since 2018: 2 appointments and 2 cessations. The latest: Jodhabhai Kayabhai Gugada ceased to be Director on 04 Nov 2020.
Frequently asked questions
JDB Pharmaceutical Project has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
JDB Pharmaceutical Project was a private limited company based in Ahmedabad, Gujarat, India. The company worked in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 15 April 2011 and is registered under CIN U24230GJ2011PTC064962. The company has been struck off by the Registrar of Companies and is no longer operational.
JDB Pharmaceutical Project had 2 directors:
- Vishal Palabhai Rudach - Director
- Devalben Bhaveshkumar Movar - Director
The CIN (Corporate Identification Number) of JDB Pharmaceutical Project is U24230GJ2011PTC064962. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of JDB Pharmaceutical Project is at Shyamdeep Advisory Services Pvt Ltd Pushpan Complex Opp. Seema Hall Sateli, Te, Ahmedabad, Gujarat, India – 380054.
JDB Pharmaceutical Project was incorporated on 15 April 2011. It is registered with the Registrar of Companies, Ahmedabad.
The latest financial statements of JDB Pharmaceutical Project on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 16 August 2020. Year-wise statements from 2015 are in the company report.
JDB Pharmaceutical Project operated in the pharma industry, in the pharmaceutical retailers and distributors segment. It worked in this industry before it was struck off.
Jodhabhai Kayabhai Gugada ceased to be Director on 04 Nov 2020. Devalben Bhaveshkumar Movar was appointed as Director on 12 Mar 2018. Devalben Bhorabhai Jam ceased to be Director on 12 Mar 2018. JDB Pharmaceutical Project has 4 board changes on record in total.
The compliance status of JDB Pharmaceutical Project is compliant as of 06 August 2026.